Grow Your Digital Health Startup in 12 Weeks

with an accelerator powered by the expertise of NUS Medicine, Asia’s leading medical school, and the backing of global venture capital firm 22Health Ventures.

The NUS Medicine Digital Health Accelerator transforms HealthTech startups through a focused 12-week journey of intensive, tailored support. Designed by medical professionals who understand the complexities of healthcare, the programme connects founders with active industry insiders who provide strategic guidance and crucial market insights. From navigating regulations to securing introductions with key decision-makers, we provide the specialised expertise, exclusive partnerships, and personalised mentorship needed to turn your innovation into a market-ready solution with global potential.

4 Reasons to Join Us

Global Networks

Access to leading clinicians, seasoned entrepreneurs and business leaders to gain a foothold in the health tech industry.

Strategic Curriculum

Learn everything from foundational business-building principles to advanced entrepreneurial skills, laying a clear path to development.

Early Funding

Earn $50K USD per company as a Simple Agreement for Future Equity (SAFE), with opportunities for progression of funding.

Personalised Mentorship

Mentors will be assigned to your startup, personalised according to your market niche and unique business needs.

Eligibility Criteria

  • NUS DATA

    Open to all startups, preferably at the pre-seed stage

  • NUS DATA

    Developing a scalable product or service with a significant total addressable market and defensible business model

  • NUS DATA

    Your company must be incorporated as a legal entity. If you wish to set up a company in Singapore, please refer to: https://www.acra.gov.sg/how-to-guides/setting-up-a-local-company

  • NUS DATA

    Commitment from Founder or Co-founder to fully participate in the 11-week programme

  • NUS DATA

    We encourage applications from Founders of all backgrounds, as we are committed to creating diverse and inclusive accelerator cohorts

NUS DATA

Frequently Asked Questions

It is an entity within NUS Medicine that aims to develop healthtech startups, by providing clear paths for development. It does this through hackathons (to facilitate ideation and product development) and accelerator programmes (for product refinement, funding, market-fit and growth).

DATA, together with 22Health Ventures, are the entities involved in the running of the Digital Health Accelerator, a 12-week long programme aimed at nurturing early-stage startups. This page allows you to sign up for the latest run of the Digital Health Accelerator.

National University of Singapore (NUS) Yong Loo Lin School of Medicine and 22Health Ventures have entered a joint partnership to create a distinctive Digital Accelerator Programme catered for the success of digital health start-ups.

The partnership capitalises on the strengths of both institutions, to provide start-ups with the confidence and resources to launch on a global stage.
National University of Singapore (NUS) Yong Loo Lin School of Medicine, Asia’s leading medical school, has deep expertise and networks in healthcare institutions. This helps start-ups to succeed in the healthcare industry.
22Health Ventures is a global venture capital fund with local commitment and global reach. From funding at early stages, to mentorship, and access to global markets, start-ups can set their eyes on making a far-reaching impact.

We are offering a standardized USD$50,000 Convertible Agreement Regarding Equity (CARE) for a post money cap of $1 million for all startups entering the programme. Further details on your current funding stage shared in the application can be discussed during the interview process.
We invite you to apply to the programme and we can clarify any concerns or issues that you may have if you progress to the subsequent interview rounds.

Featured Story

Demo Day 2024 Highlights Bold Ideas of Our Graduating Startups

Five outstanding startups from our inaugural cohort took center stage, pitched their innovative solutions to an engaged audience of industry leaders and investors, and showcased their potential in transforming healthcare.